BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16997602)

  • 1. Clinical response to intra-articular injections of hylan G-F 20 in symptomatic hip osteoarthritis: the OMERACT-OARSI criteria applied to the results of a pilot study.
    Conrozier T; Bertin P; Bailleul F; Mathieu P; Charlot J; Vignon E; Treves R; Chevalier X
    Joint Bone Spine; 2006 Dec; 73(6):705-9. PubMed ID: 16997602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the use of intra-articular injections as a treatment for painful hip osteoarthritis: a randomized, double-blind, multicenter, parallel-group study comparing a single 6-mL injection of hylan G-F 20 with saline.
    Brander V; Skrepnik N; Petrella RJ; Jiang GL; Accomando B; Vardanyan A
    Osteoarthritis Cartilage; 2019 Jan; 27(1):59-70. PubMed ID: 30223023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open-label, multicentre, pilot study.
    Conrozier T; Bertin P; Mathieu P; Charlot J; Bailleul F; Treves R; Vignon E; Chevalier X
    Clin Exp Rheumatol; 2003; 21(5):605-10. PubMed ID: 14611109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.
    Conrozier T; Jerosch J; Beks P; Kemper F; Euller-Ziegler L; Bailleul F; Chevalier X
    Arch Orthop Trauma Surg; 2009 Mar; 129(3):417-23. PubMed ID: 18365224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis.
    Migliore A; Tormenta S; Martin LS; Valente C; Massafra U; Granata M; Alimonti A
    Clin Rheumatol; 2005 Jun; 24(3):285-9. PubMed ID: 15592903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-articular administration of hylan G-F 20 in patients with symptomatic hip osteoarthritis: tolerability and effectiveness in a large cohort study in clinical practice.
    Migliore A; Tormenta S; Massafra U; Bizzi E; Iannessi F; Alimonti A; Granata M
    Curr Med Res Opin; 2008 May; 24(5):1309-16. PubMed ID: 18373891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, efficacy and predictive factors of efficacy of a single intra-articular injection of non-animal-stabilized-hyaluronic-acid in the hip joint: results of a standardized follow-up of patients treated for hip osteoarthritis in daily practice.
    Conrozier T; Couris CM; Mathieu P; Merle-Vincent F; Piperno M; Coury F; Belin V; Tebib J; Vignon E
    Arch Orthop Trauma Surg; 2009 Jun; 129(6):843-8. PubMed ID: 19011882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does joint effusion influence the clinical response to a single Hylan GF-20 injection for hip osteoarthritis?
    Rennesson-Rey B; Rat AC; Chary-Valckenaere I; Bettembourg-Brault I; Juge N; Dintinger H; Pourel J; Loeuille D
    Joint Bone Spine; 2008 Mar; 75(2):182-8. PubMed ID: 18314368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of Hylan G-F 20 in shoulder osteoarthritis with an intact rotator cuff. Open-label prospective multicenter study.
    Noël E; Hardy P; Hagena FW; Laprelle E; Goebel F; Faure C; Favard L; Gaudin P; Christ R; Baudot C; Dietl J; Goupille P
    Joint Bone Spine; 2009 Dec; 76(6):670-3. PubMed ID: 19945321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up.
    Migliore A; Tormenta S; Martin Martin LS; Iannessi F; Massafra U; Carloni E; Monno D; Alimonti A; Granata M
    Clin Rheumatol; 2006 May; 25(3):389-93. PubMed ID: 16249827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT-OARSI.
    Bellamy N; Bell MJ; Goldsmith CH; Pericak D; Walker V; Raynauld JP; Torrance GW; Tugwell P; Polisson R
    Osteoarthritis Cartilage; 2005 Feb; 13(2):104-10. PubMed ID: 15694571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial.
    Chevalier X; Jerosch J; Goupille P; van Dijk N; Luyten FP; Scott DL; Bailleul F; Pavelka K
    Ann Rheum Dis; 2010 Jan; 69(1):113-9. PubMed ID: 19304567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of hylan G-F 20 for symptomatic glenohumeral osteoarthritis: a prospective, pilot study.
    Brander VA; Gomberawalla A; Chambers M; Bowen M; Nuber G
    PM R; 2010 Apr; 2(4):259-67. PubMed ID: 20430327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentre, prospective, open study to evaluate the safety and efficacy of hylan G-F 20 in knee osteoarthritis subjects presenting with pain following arthroscopic meniscectomy.
    Huskin JP; Vandekerckhove B; Delincé P; Verdonk R; Dubuc JE; Willems S; Hardy P; Blanco FJ; Charrois O; Handelberg F
    Knee Surg Sports Traumatol Arthrosc; 2008 Aug; 16(8):747-52. PubMed ID: 18536906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there evidence to support the inclusion of viscosupplementation in the treatment paradigm for patients with hip osteoarthritis?
    Conrozier T; Vignon E
    Clin Exp Rheumatol; 2005; 23(5):711-6. PubMed ID: 16173254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-Hoc analysis of a head-to-head hyaluronic acid comparison in knee osteoarthritis using the 2004 OMERACT-OARSI responder criteria.
    Onel E; Kolsun K; Kauffman JI
    Clin Drug Investig; 2008; 28(1):37-45. PubMed ID: 18081359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hylan G-F 20 improves hip osteoarthritis: a prospective, randomized study.
    Spitzer AI; Bockow BI; Brander VA; Yates JW; MacCarter DK; Gudger GK; Haller S; Lake SL; Magilavy DB
    Phys Sportsmed; 2010 Jun; 38(2):35-47. PubMed ID: 20631462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of ultrasound-guided intra-articular hylan G-F 20 injection in osteoarthritis of the hip: a pilot study.
    Caglar-Yagci H; Unsal S; Yagci I; Dulgeroglu D; Ozel S
    Rheumatol Int; 2005 Jun; 25(5):341-4. PubMed ID: 15004721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy and safety of two different molecular weight (MW) hyaluronans F60027 and Hylan G-F20 in symptomatic osteoarthritis of the knee (KOA). Results of a non inferiority, prospective, randomized, controlled trial.
    Maheu E; Zaim M; Appelboom T; Jeka S; Trc T; Berenbaum F; Maasalu K; Berenbaum F
    Clin Exp Rheumatol; 2011; 29(3):527-35. PubMed ID: 21722501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intra-articular treatment with Hylan G-F 20 under ultrasound guidance in hip osteoarthritis. Clinical results after 12 months follow-up].
    Migliore A; Tormenta S; Valente C; Massafra U; Martin Martin LS; Carmenini E; Bernardini A; Alimonti A
    Reumatismo; 2005; 57(1):36-43. PubMed ID: 15776145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.